About 14,100 results
Open links in new tab
  1. PATIENT FACT SHEET Copyright © 2024 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form ...

  2. Diabetic Hypoglycemia: Symptoms and Treatments

    Nov 19, 2024 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Diabetic hypoglycemia is when your blood sugar falls below …

  3. Multiple Endocrine Neoplasia Type 1 Treatment Guidelines ...

    5 days ago · Background. The American Association of Clinical Endocrinology (AACE) developed an evidence-based consensus statement for the diagnosis and management of multiple …

  4. FDA Approves Welireg for Pheochromocytoma and Paraganglioma

    May 19, 2025 · The Food and Drug Administration (FDA) has approved Welireg ™ (belzutifan) for the treatment of adult and pediatric patients aged 12 years and older with locally advanced, …

  5. Understanding How GLP-1 RAs Achieve Sustained Weight Loss

    May 16, 2025 · GLP-1 RAs are incretin hormones that stimulate insulin secretion, delay gastric emptying, and inhibit glucagon secretion, which are mechanisms that reduce hunger and …

  6. Diabetes and Erectile Dysfunction - Endocrinology Advisor

    Nov 29, 2024 · Erectile dysfunction is a persistent pattern of being unable to attain and/or maintain a penile erection sufficient for sexual satisfaction. 1 It is a common problem, affecting …

  7. Olezarsen Cuts Triglyceride Levels in Patients With Moderate ...

    6 days ago · Both doses of olezarsen significantly reduced triglyceride levels at 6 months compared with placebo (placebo-adjusted reduction, 50mg: 58%; 80mg: 61%; P .0001). …

  8. Tirzepatide Discontinuation Reduces Cardiometabolic Improvements

    May 20, 2025 · Short-term discontinuation of long-term tirzepatide leads to reduced improvements in cardiometabolic risk factors among patients with prediabetes, especially those with body …

  9. GLP-1 Agonists - Endocrinology Advisor

    Oct 8, 2024 · Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are a newer class of medications that are US Food and Drug Administration (FDA)-approved to manage type 2 …

  10. HHS, FDA Begin 'Operation Stork Speed' to Improve Quality of …

    May 21, 2025 · The FDA has requested to gather public input, which will be used to evaluate whether current nutrient requirements need to be updated based on the most recent scientific …